Welby

Welby FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Welby (4438.T) as of Oct 19, 2026 is 61.57 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 96.48 % — a change of -36.18% (lower).

FCF Conversion

61.57 %

YoY

-36.18%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Welby is 2025 61.57 % . FCF Conversion Rate (FCF/EBITDA) of Welby was 2024 96.48 % . It decreases by -36.18% lower compared to the previous year.

The Welby FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-3.18 JPY
Jan 1, 2019
2,071.95 JPY
Jan 1, 2020
43.92 JPY
Jan 1, 2021
88.36 JPY
Jan 1, 2022
-433.11 JPY
Jan 1, 2023
35.05 JPY
Jan 1, 2024
96.48 JPY
Jan 1, 2025
61.57 JPY
The Welby FCF Conversion history
YEARFCF ConversionYoY
61.57 %-36.18%
96.48 %+175.26%
35.05 %-108.09%
-433.11 %-590.17%
88.36 %+101.16%
43.92 %-97.88%
2,071.95 %-65,230.19%
-3.18 %-107.37%
43.14 %-58.57%
104.12 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Welby Stock analysis

What does Welby do? Welby Inc is a Japanese company operating in the Health Care sector, headquartered in Chuo-Ku, Tokyo. The company has 40 employees and went public on March 29, 2019, with the ticker 4438.T and ISIN JP3155410008. Welby Inc develops patient health record platform services, focusing on creating a personal health record (PHR) platform within the medical field. The company provides two main services: a disease solution service, which involves developing PHR platforms for pharmaceutical companies upon request, and Welby My Carte, a cloud-based service designed to support patients in managing their daily health habits, particularly for conditions such as diabetes and hypertension. The company's website is https://welby.jp/. Welby Inc operates with a focus on digital health solutions, aiming to enhance patient self-management and provide tailored health record systems for medical and pharmaceutical partners. The company's business model centers on delivering technology-driven health management tools that support both healthcare providers and patients. As a publicly traded company, Welby Inc is listed on the Tokyo Stock Exchange. The company's operations are based in Chuo-Ku, Tokyo, and it serves a market that includes healthcare institutions and pharmaceutical firms seeking digital health solutions. The firm's services are designed to improve patient engagement and health outcomes through accessible, technology-based platforms. Welby is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Welby stock

FCF Conversion Rate (FCF/EBITDA) of Welby is 61.57 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Welby changed from 96.48 % to 61.57 %, representing a -36.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Welby since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Welby with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Welby

All Key Metrics — Welby